Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas - PubMed (original) (raw)

. 2003 May 20;105(1):98-100.

doi: 10.1002/ijc.11029.

Affiliations

• PMID: 12672037
• DOI: 10.1002/ijc.11029

Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas

Anthony P Polednak. Int J Cancer. 2003.

No abstract available

PubMed Disclaimer

Similar articles

• Trends in esophageal cancer incidence by histology, United States, 1998-2003.
  Trivers KF, Sabatino SA, Stewart SL. Trivers KF, et al. Int J Cancer. 2008 Sep 15;123(6):1422-8. doi: 10.1002/ijc.23691. Int J Cancer. 2008. PMID: 18546259
• Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
  Saad AM, Al-Husseini MJ, Elgebaly A, Aboshady OA, Salahia S, Abdel-Rahman O. Saad AM, et al. Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):417-423. doi: 10.1080/17474124.2018.1426458. Epub 2018 Jan 16. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29316808
• Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.
  Dubecz A, Gall I, Solymosi N, Schweigert M, Peters JH, Feith M, Stein HJ. Dubecz A, et al. J Thorac Oncol. 2012 Feb;7(2):443-7. doi: 10.1097/JTO.0b013e3182397751. J Thorac Oncol. 2012. PMID: 22173700
• The changing epidemiology of esophageal adenocarcinoma.
  Wei JT, Shaheen N. Wei JT, et al. Semin Gastrointest Dis. 2003 Jul;14(3):112-27. Semin Gastrointest Dis. 2003. PMID: 14653411 Review.
• Incidence, epidemiology, and etiology of esophageal cancer.
  Gamliel Z. Gamliel Z. Chest Surg Clin N Am. 2000 Aug;10(3):441-50. Chest Surg Clin N Am. 2000. PMID: 10967749 Review.

Cited by

• Efficacy and safety of PD-1 Monoclonal antibodies in the treatment of esophageal squamous cell carcinoma: Systematic review and meta Regression.
  Ameer FA, G A, Ibrahim A, Al-Shammari AS. Ameer FA, et al. Heliyon. 2024 Jul 14;10(14):e34042. doi: 10.1016/j.heliyon.2024.e34042. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39148999 Free PMC article. Review.
• Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3).
  Matz M, Valkov M, Šekerija M, Luttman S, Caldarella A, Coleman MP, Allemani C; CONCORD Working Group. Matz M, et al. Cancer Commun (Lond). 2023 Sep;43(9):963-980. doi: 10.1002/cac2.12457. Epub 2023 Jul 24. Cancer Commun (Lond). 2023. PMID: 37488785 Free PMC article.
• Endoscopic luminal stenting: Current applications and future perspectives.
  Moutzoukis M, Argyriou K, Kapsoritakis A, Christodoulou D. Moutzoukis M, et al. World J Gastrointest Endosc. 2023 Apr 16;15(4):195-215. doi: 10.4253/wjge.v15.i4.195. World J Gastrointest Endosc. 2023. PMID: 37138934 Free PMC article. Review.
• Risk factors for distant metastasis and prognosis in stage T1 esophageal cancer: A population-based study.
  Zhu K, Jia M, Ji L, Wang G. Zhu K, et al. Front Surg. 2023 Jan 6;9:988460. doi: 10.3389/fsurg.2022.988460. eCollection 2022. Front Surg. 2023. PMID: 36684271 Free PMC article.
• The Incidence Rate of Esophageal Cancer in Saudi Arabia: An Observational and a Descriptive Epidemiological Analyses.
  Almatroudi A. Almatroudi A. Front Public Health. 2022 Mar 23;10:818691. doi: 10.3389/fpubh.2022.818691. eCollection 2022. Front Public Health. 2022. PMID: 35400030 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Wiley

• Medical

  • MedlinePlus Health Information